These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34069262)

  • 1. Mass Spectrometry-Based Glycoproteomics and Prostate Cancer.
    Gabriele C; Prestagiacomo LE; Cuda G; Gaspari M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues.
    Li Y; Tian Y; Rezai T; Prakash A; Lopez MF; Chan DW; Zhang H
    Anal Chem; 2011 Jan; 83(1):240-5. PubMed ID: 21141837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012.
    Leymarie N; Griffin PJ; Jonscher K; Kolarich D; Orlando R; McComb M; Zaia J; Aguilan J; Alley WR; Altmann F; Ball LE; Basumallick L; Bazemore-Walker CR; Behnken H; Blank MA; Brown KJ; Bunz SC; Cairo CW; Cipollo JF; Daneshfar R; Desaire H; Drake RR; Go EP; Goldman R; Gruber C; Halim A; Hathout Y; Hensbergen PJ; Horn DM; Hurum D; Jabs W; Larson G; Ly M; Mann BF; Marx K; Mechref Y; Meyer B; Möginger U; Neusüβ C; Nilsson J; Novotny MV; Nyalwidhe JO; Packer NH; Pompach P; Reiz B; Resemann A; Rohrer JS; Ruthenbeck A; Sanda M; Schulz JM; Schweiger-Hufnagel U; Sihlbom C; Song E; Staples GO; Suckau D; Tang H; Thaysen-Andersen M; Viner RI; An Y; Valmu L; Wada Y; Watson M; Windwarder M; Whittal R; Wuhrer M; Zhu Y; Zou C
    Mol Cell Proteomics; 2013 Oct; 12(10):2935-51. PubMed ID: 23764502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
    Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
    Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry based glycoproteomics--from a proteomics perspective.
    Pan S; Chen R; Aebersold R; Brentnall TA
    Mol Cell Proteomics; 2011 Jan; 10(1):R110.003251. PubMed ID: 20736408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplexed quantitative proteomics in prostate cancer biomarker development.
    Gao Y; Kim H; Kitata RB; Lin TT; Swensen AC; Shi T; Liu T
    Adv Cancer Res; 2024; 161():31-69. PubMed ID: 39032952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery.
    Lee J; Hua S; Lee SH; Oh MJ; Yun J; Kim JY; Kim JH; Kim JH; An HJ
    Anal Bioanal Chem; 2018 Feb; 410(6):1617-1629. PubMed ID: 29285644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary biomarkers in prostate cancer detection and monitoring progression.
    Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
    Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile.
    Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J
    J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation of prostate specific antigen and its potential diagnostic applications.
    Vermassen T; Speeckaert MM; Lumen N; Rottey S; Delanghe JR
    Clin Chim Acta; 2012 Oct; 413(19-20):1500-5. PubMed ID: 22722018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera.
    Totten SM; Adusumilli R; Kullolli M; Tanimoto C; Brooks JD; Mallick P; Pitteri SJ
    Sci Rep; 2018 Apr; 8(1):6509. PubMed ID: 29695737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen.
    Kammeijer GSM; Nouta J; de la Rosette JJMCH; de Reijke TM; Wuhrer M
    Anal Chem; 2018 Apr; 90(7):4414-4421. PubMed ID: 29502397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry.
    Jia X; Chen J; Sun S; Yang W; Yang S; Shah P; Hoti N; Veltri B; Zhang H
    Proteomics; 2016 Dec; 16(23):2989-2996. PubMed ID: 27749016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoproteomics: identifying the glycosylation of prostate specific antigen at normal and high isoelectric points by LC-MS/MS.
    Song E; Mayampurath A; Yu CY; Tang H; Mechref Y
    J Proteome Res; 2014 Dec; 13(12):5570-80. PubMed ID: 25327667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation on core-fucosylated prostate-specific antigen as a refined biomarker for differentiation of benign prostate hyperplasia and prostate cancer of different aggressiveness.
    Lang R; Rolny V; Leinenbach A; Karl J; Swiatek-de Lange M; Kobold U; Schrader M; Krause H; Mueller M; Vogeser M
    Tumour Biol; 2019 Mar; 41(3):1010428319827223. PubMed ID: 30907281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based expression profiling of clinical prostate cancer.
    Wright ME; Han DK; Aebersold R
    Mol Cell Proteomics; 2005 Apr; 4(4):545-54. PubMed ID: 15695425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer proteomics.
    Masters JR
    OMICS; 2011 Mar; 15(3):169-71. PubMed ID: 21319990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis - mass spectrometry.
    Moran AB; Domínguez-Vega E; Nouta J; Pongracz T; de Reijke TM; Wuhrer M; Lageveen-Kammeijer GSM
    J Proteomics; 2021 Apr; 238():104148. PubMed ID: 33618028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics in diagnosis of prostate cancer.
    Davalieva K; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Spectrometry-Based Chemical and Enzymatic Methods for Global Analysis of Protein Glycosylation.
    Xiao H; Suttapitugsakul S; Sun F; Wu R
    Acc Chem Res; 2018 Aug; 51(8):1796-1806. PubMed ID: 30011186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.